Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrate

Efficacy and safety of monoclonal antibody purified factor IX concentrate in haemophilia B patients undergoing surgical procedures.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Lack of immune response to mouse IgG in previously untreated haemophilia A and haemophilia B patients treated with monoclonal antibody purified factor VIII and factor IX preparations.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Factors associated with failure to correct the international normalised ratio following fresh frozen plasma administration among patients treated for warfarin-related major bleeding. An analysis of electronic health records.

Thrombosis and haemostasis·2012

Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records.

Journal of thrombosis and haemostasis : JTH·2012

The association between cytomegalovirus immune globulin and long-term recipient and graft survival following liver transplantation.

Transplant infectious disease : an official journal of the Transplantation Society·2011

Presurgical pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in patients with von Willebrand's disease (VWD) has limited value in dosing for surgery.

Haemophilia : the official journal of the World Federation of Hemophilia·2011

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Olive Leaves for Functional Herbal Infusions: Effects of Post-Harvest Processing on Bioactive Properties, α-Amylase Inhibition Activity and Consumer Safety.

Molecules (Basel, Switzerland)·2026

Comparative Evaluation of Bioactive Compounds, Antioxidant Capacity, and Quality Traits of Raspberry Cultivars.

Molecules (Basel, Switzerland)·2026

Comparative Phytochemical and Biological Evaluation of Walnut Septum and Pellicle Extracts in Chemical, Computational, and Cell-Based Models.

Pharmaceuticals (Basel, Switzerland)·2026

Profiling the Main Cell Wall Polysaccharides of the Cultivated Eggplant (Solanum melongena L.) Using CoMPP and ELISA.

Plants (Basel, Switzerland)·2026

Genome-Wide Identification and Functional Characterization of the Carboxylesterase (CXE) Gene Family in Melon (Cucumis melo L.): CmCXE7 as a Cold-Responsive Regulator of Ester Metabolism.

Plants (Basel, Switzerland)·2026

Screening of Metabolite Biomarkers for Antioxidant and Glycosidase Inhibitory Activities from Oat Resources.

Foods (Basel, Switzerland)·2026

Related Experiment Videos

Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrate

Related Concept Videos

Efficacy and safety of monoclonal antibody purified factor IX concentrate in haemophilia B patients undergoing surgical procedures.

Lack of immune response to mouse IgG in previously untreated haemophilia A and haemophilia B patients treated with monoclonal antibody purified factor VIII and factor IX preparations.

Factors associated with failure to correct the international normalised ratio following fresh frozen plasma administration among patients treated for warfarin-related major bleeding. An analysis of electronic health records.

Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records.

The association between cytomegalovirus immune globulin and long-term recipient and graft survival following liver transplantation.

Presurgical pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in patients with von Willebrand's disease (VWD) has limited value in dosing for surgery.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Olive Leaves for Functional Herbal Infusions: Effects of Post-Harvest Processing on Bioactive Properties, α-Amylase Inhibition Activity and Consumer Safety.

Comparative Evaluation of Bioactive Compounds, Antioxidant Capacity, and Quality Traits of Raspberry Cultivars.

Comparative Phytochemical and Biological Evaluation of Walnut Septum and Pellicle Extracts in Chemical, Computational, and Cell-Based Models.

Profiling the Main Cell Wall Polysaccharides of the Cultivated Eggplant (Solanum melongena L.) Using CoMPP and ELISA.

Genome-Wide Identification and Functional Characterization of the Carboxylesterase (CXE) Gene Family in Melon (Cucumis melo L.): CmCXE7 as a Cold-Responsive Regulator of Ester Metabolism.

Screening of Metabolite Biomarkers for Antioxidant and Glycosidase Inhibitory Activities from Oat Resources.

Related Experiment Videos

Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrate

Related Concept Videos

Related Articles